Cephalalgia Reports
Cephalalgia Reports is a peer reviewed, Open Access publication published on behalf of the International Headache Society (IHS), the world’s leading membership organization for those with a professional commitment to helping people affected by headache. The journal provides an international forum for research on all aspects of headache and facial pain including preclinical and clinical research, diagnosis and treatment referred to the head and face.
The journal publishes international content encompassing a wide variety of article types.
Topics of interest include:
• diagnosis and management of primary and secondary headaches and related syndromes
• pathophysiology
• mechanisms
• pharmacology
• epidemiology and burden
• imaging
• genetics
• biomarkers
• e-health and artificial intelligence
• medico-legal aspects
• pharmacoeconomics
All articles will be fully peer-reviewed, published rapidly online within days of acceptance and made available on an Open Access basis.
Published with the same internationally respected editorial team and rigorous peer review as Cephalalgia, Cephalalgia Reports operates under an open access publishing model, where an article processing charge (APC)* enables the article to be free to access.
Content published is available for anyone, anywhere to read, offering truly global dissemination. This includes those in developing countries and others who may not otherwise have access to the content, fulfilling one of the IHS's primary objectives to advance headache science, education, and management, and promote headache awareness worldwide.
* The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
This journal is a member of the Committee on Publication Ethics (COPE).
- Research results:
- Original research (basic science and articles with a clinical emphasis)
- Randomised Controlled Trials (RCTS) with negative outcomes
- Case studies
- Feasibility and pilot trials which may stimulate therapeutic innovation
- Reports providing regional relevance which validate and add to existing studies
- Registered reports
- Qualitative and quantitative studies
- Scientifically rigorous pathophysiological and pharmacological studies
- Review articles (narrative reviews and systematic reviews)
- Educational pieces on technical reports and best practice
- Current topics and opinion pieces (such as clinical perspectives, emerging observations with translational potential not yet realized and brief communications)
This journal is a member of the Committee on Publication Ethics (COPE).
| Simona Sacco, MD, PhD | University of L’Aquila, Italy |
| Wendy Krank | Managing Editor, USA |
| Marcelo Valença, MD, PhD | Federal University of Pernambuco, Recife, Brazil |
| James S. McGinley, PhD | Vector Psychometric Group, USA |
| Peter J. Koehler, MD, PhD, FAAN | Faculty of Health, Medicine and Life Studies, Maastricht University, Netherlands |
| Faisal Mohammad Amin, MD, PhD | Glostrup Hospital, University of Copenhagen, Denmark |
| Edoardo Caronna, MD, PhD | Vall d'Hebron Research Institute, Spain |
| Catherine D. Chong, MD | Mayo Clinic College of Medicine, USA |
| Roberto De Icco, MD | University of Pavia, Italy |
| Daniel Noam Lax, MD | Montefiore Medical Center, USA |
| Francesca Puledda, MD, PhD | King's College London, UK |
| Marta Vila-Pueyo, PhD | Vall d'Hebron Research Institute, Spain |
| Faraidoon Haghdoost, MD, PhD | George Institute for Global Health (UNSW), Sydney, Australia |
| Nina Riggins, MD, PhD, FAAN | Neuron Clinic, USA |
| Peter J. Goadsby, MD, PhD, DSc, FRACP, FRCP | King's College London, UK |
| David W. Dodick, MD, FAAN | Mayo Clinic College of Medicine, USA |
| Frank Andrasik, PhD | University of Memphis, USA |
| Sait Ashina, MD | Beth Israel Deaconess Medical Center, USA |
| Rafael Benoliel, OM | Rutgers University, USA |
| Rami Burstein, PhD | Beth Israel Deaconess Medical Center, USA |
| Gianluca Coppola, MD, PhD | Sapienza University of Rome Polo Pontino, Italy |
| Hans-Christoph Diener, MD, PhD | University Essen, Essen, Germany |
| Anne Ducros, MD, PhD | Montpellier University Hospital, Montpellier, France |
| Stefan Evers, MD, PhD | University of Münster, Germany |
| Larus S. Gudmundsson, MSc, PhD | University of Iceland, Iceland |
| Andrew Hershey, MD, PhD, FAHS | University of Cincinnati, USA |
| Philip R. Holland, BSc, PhD | King's College London, UK |
| Mi Ji Lee, MD, PhD | Samsung Medical Center, Sungkyunkwan University School of Medicine, South Korea |
| Karl Messlinger, Dipl. Biol. Dr. med. Dr. med habil | University of Erlangen Nurenberg, Germany |
| Teshamae S. Monteith, MD | University of Miami Hospital, USA |
| Kuan-Po Peng, MD | Department of Systems Neuroscience, University Clinic Hamburg Eppendorf (UKE), Germany |
| Patricia Pozo-Rosich, MD, PhD | Vall d'Hebron University Hospital, Spain |
| Todd Schwedt, MD | Mayo Clinic College of Medicine, USA |
| Henrick Winther Schytz, MD, DMSc, PhD | Danish Headache Center, Glostrup, Denmark |
| Cristina Tassorelli, MD, PhD, FEAN | Neurological Institute C Mondino Foundation, Italy |
| Erling A. Tronvik, MD | Norwegian University of Science and Technology, Norway |
| Marcelo Valença, MD, PhD | Federal University of Pernambuco, Recife, Brazil |
| Shuu-Jiun Wang, MD | Taipei Veterans General Hospital, Taiwan |
| Alessandro S. Zagami, MD | Prince of Wales Hospital, Institute of Neurological Sciences, Sydney, Australia |
Manuscript submission guidelines can be accessed on Sage Journals.